TherapeuticsMD | TXMD - Ordinary Share Capital


TherapeuticsMD reported $11K in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 608K Jun/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Cipla INR 807.87M 88K Sep/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.72M 170K Jun/2026
CSL USD 482.13M 93.87M Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
TherapeuticsMD USD 11K 0 Sep/2023